SCHEMBL21807299

SCHEMBL21807299

Cc1noc2cccc(Br)c12

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDR P35968 3/20 0.38
FLT3 P36888 3/20 0.38
MAP4K4 O95819 2/20 0.38
PDGFRB P09619 2/20 0.38
PIM1 P11309 2/20 0.38
FGFR1 P11362 2/20 0.38
PDGFRA P16234 2/20 0.38
PRKACA P17612 2/20 0.38
LTK P29376 2/20 0.38
GRK5 P34947 2/20 0.38
CDK8 P49336 2/20 0.38
CDK7 P50613 2/20 0.38
CDK9 P50750 2/20 0.38
LIMK1 P53667 2/20 0.38
MAP2K1 Q02750 2/20 0.38
ACVR1 Q04771 2/20 0.38
MST1R Q04912 2/20 0.38
MAP4K2 Q12851 2/20 0.38
ROCK1 Q13464 2/20 0.38
DYRK1A Q13627 2/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8404487 0.79 CYP1A2 (0.41) KDRFLT3MAP4K4PDGFRBPIM1
SCHEMBL420820 0.76 KDR (0.54) KDRFLT3MAP4K4PDGFRBPIM1
SCHEMBL21783714 0.76 KDR (0.45) KDRFLT3MAP4K4PDGFRBPIM1
SCHEMBL28133259 0.76 LMNA (0.47) KDRFLT3MAP4K4PDGFRBPIM1
SCHEMBL3195416 0.76 KCNA5 (0.46) KDRFLT3MAP4K4PDGFRBPIM1
SCHEMBL29314341 0.76 KDR (0.38) KDRFLT3MAP4K4PDGFRBPIM1
SCHEMBL30784448 0.76 KDR (0.38) KDRFLT3MAP4K4PDGFRBPIM1
SCHEMBL28133272 0.76 KDR (0.38) KDRFLT3MAP4K4PDGFRBPIM1
SCHEMBL21660472 0.76 KCNA5 (0.37) KDRFLT3MAP4K4PDGFRBPIM1
SCHEMBL13305129 0.73 KCNA5 (0.38) KDRFLT3MAP4K4PDGFRBPIM1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3852790-A1 INHIBITING UBIQUITIN SPECIFIC PEPTIDASE 9X Forma Therapeutics, Inc. (US) 2021-07-28 EP disclosed
CN-113164571-A Inhibition of ubiquitin-specific peptidase 9X 福马治疗股份有限公司 2021-07-23 CN disclosed
WO-2020061261-A1 INHIBITING UBIQUITIN SPECIFIC PEPTIDASE 9X FORMA THERAPEUTICS, INC. (US) 2020-03-26 WO disclosed
CN-106543095-A It is a kind of based on one pot of method for preparing benzoisoxazole of 2 hydroxy acetophenone oximes and its derivant 江苏大学 2017-03-29 CN disclosed